How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research BD Diagnostic Systems in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
6 clearance records and 13 recall records in the covered releases, across 1 source company names and 9 product codes. Dated history runs from Feb 28, 2003 to May 28, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| BD BACTEC FXI Culture SystemK260213 · MDB | BD Diagnostic Systems | 510(k) | May 28, 2026FDA decision date |
| BD, Brucella melitensis AntigenZ-0311-05 · GSO | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Salmonella O Group D Antigen (9-12) (Typhoid O)Z-0312-05 · GNC | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Salmonella Somatic Polyvalent Antiserum (A,B,D)Z-0313-05 · GSN | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Brucella abortus AntigenZ-0314-05 · GSO | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Salmonella Flagellar d Antigen (Typhoid H)Z-0315-05 · GNC | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Salmonella O Group A Antigen (1-2-12)Z-0316-05 · GNC | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Salmonella O Group B Antigen (1-4-5-12)Z-0317-05 · GNC | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Salmonella Flagellar Polyvalent Antiserum (a,b,d)Z-0318-05 · GSN | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Proteus OX19 AntigenZ-0319-05 · GSY | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Francisella tularensis AntigenZ-0320-05 · GSK | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Proteus Polyvalent Antiserum (OXK, OX2, OX19)Z-0321-05 · GSY | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Brucella Postive Control Antiserum (AMS)Z-0322-05 · GSM | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| BD, Febrile Antigen Negative ControlZ-0323-05 · GSM | BD Diagnostic Systems | Recall | Dec 16, 2004FDA classification date |
| PASCO MIC AND MIC/ID PANELS, GEMIFLOXACIN (STREP)K032518 · JWY | Bd Diagnostic Systems | 510(k) | Sep 15, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFOTAXIME 0.5-64 UG/MLK032153 · LON | Bd Diagnostic Systems | 510(k) | Sep 11, 2003FDA decision date |
| PASCO MIC AND MIC/ID PANELSK032259 · JWY | Bd Diagnostic Systems | 510(k) | Aug 19, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MEROPENEM 0.25-16 UG/MLK031429 · LON | Bd Diagnostic Systems | 510(k) | Jun 6, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - NORFLOXACIN 0.25 - 16 UG/MLK030091 · LON | Bd Diagnostic Systems | 510(k) | Feb 28, 2003FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.